Gregory Abel, MD, MPH, MFA

Gregory Abel, MD, MPH, MFA

Associate Professor of Medicine, Dana-Farber Cancer Institute
Member, HMS Center for Bioethics

Gregory Abel, MD, MPH, MFA is an outcomes researcher and hematologic oncologist at Dana-Farber Cancer Institute (DFCI) and Harvard Medical School. He helps run DFCI’s Older Adult Hematologic Malignancy (OHM) geriatric hematology research program, serves as Co-Chair of the DFCI Ethics Advisory Committee, and directs DFCI’s Clinical Ethics Service. The Abel research lab applies health services research methods to understand the experiences of patients with blood cancers and develop interventions to improve their care. Dr. Abel is also interested in evaluating how cancer and its therapies affect outcomes such as function and quality of life. Through his work and collaboration with researchers in oncology, hematology, geriatrics, bioethics, and energy balance, he aims to ameliorate the impact of hematologic malignancies and their treatment from diagnosis to the end of life.

Publications View
Association of Polypharmacy and Potentially Inappropriate Medications With Frailty Among Older Adults With Blood Cancers.
Authors: Authors: Hshieh TT, DuMontier C, Jaung T, Bahl NE, Hawley CE, Mozessohn L, Stone RM, Soiffer RJ, Driver JA, Abel GA.
J Natl Compr Canc Netw
View full abstract on Pubmed
Randomized controlled trial of geriatric consultation versus standard care in older adults with hematologic malignancies.
Authors: Authors: DuMontier C, Uno H, Hshieh T, Zhou G, Chen R, Magnavita ES, Mozessohn L, Javedan H, Stone RM, Soiffer RJ, Driver JA, Abel GA.
Haematologica
View full abstract on Pubmed
Impact of Allocation on Survival During Intermittent Chemotherapy Shortages: A Modeling Analysis.
Authors: Authors: Hantel A, McManus ML, Wadleigh M, Cotugno M, Abel GA.
J Natl Compr Canc Netw
View full abstract on Pubmed
Age-related diseases of inflammation in myelodysplastic syndrome and chronic myelomonocytic leukemia.
Authors: Authors: Weeks LD, Marinac CR, Redd R, Abel G, Lin A, Agrawal M, Stone RM, Schrag D, Ebert BL.
Blood
View full abstract on Pubmed
Precancer and cancer-associated depression and anxiety among older adults with blood cancers in the United States.
Authors: Authors: Kuczmarski TM, Jaung T, Mancuso CE, Mozessohn L, Roemer L, Abel GA, Odejide OO.
Blood Adv
View full abstract on Pubmed
Prognostic value of disease risk score versus gait speed in older adults with lymphoma.
Authors: Authors: Mozessohn L, Zhang L, Odejide OO, Chen R, Buckstein R, Soiffer RJ, Castillo JJ, Driver JA, Abel GA.
Leuk Lymphoma
View full abstract on Pubmed
Racial and ethnic enrollment disparities and demographic reporting requirements in acute leukemia clinical trials.
Authors: Authors: Hantel A, Luskin MR, Garcia JS, Stock W, DeAngelo DJ, Abel GA.
Blood Adv
View full abstract on Pubmed
Objective performance tests of cognition and physical function as part of a virtual geriatric assessment.
Authors: Authors: Bahl NE, Magnavita ES, Hshieh T, Testa M, Kim D, Manor B, Driver JA, Abel GA, DuMontier C.
J Geriatr Oncol
View full abstract on Pubmed
Peri-transfusion quality-of-life assessment for patients with myelodysplastic syndromes.
Authors: Authors: Abel GA, Klepin HD, Magnavita ES, Jaung T, Lu W, Shallis RM, Hantel A, Bahl NE, Dellinger-Johnson R, Winer ES, Zeidan AM.
Transfusion
View full abstract on Pubmed
Defining Multimorbidity and Its Impact in Older United States Veterans Newly Treated for Multiple Myeloma.
Authors: Authors: Fillmore NR, DuMontier C, Yildirim C, La J, Epstein MM, Cheng D, Cirstea D, Yellapragada S, Abel GA, Gaziano JM, Do N, Brophy M, Kim DH, Munshi NC, Driver JA.
J Natl Cancer Inst
View full abstract on Pubmed